findmyKOL
Clinical trialNCT07142252RecruitingPhase 2Interventional

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

SponsorNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrollment66Type 1 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

    Megan Levings, PhD
    Not, yet, recruiting
United States
  • Barbara Davis Center for Diabetes

    Aurora, Colorado, United States

    Peter Gottlieb, MD
    Recruiting
  • University of Florida

    Gainesville, Florida, United States

    Timothy Foster, MD
    Recruiting
  • University of Miami

    Miami, Florida, United States

    David Baidal, MD
    Recruiting
  • Joslin Diabetes Center

    Boston, Massachusetts, United States

    Jason Gaglia, MD
    Recruiting
  • Columbia University

    New York, New York, United States

    Jacqueline Lonier, MD
    Recruiting
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    Ingrid Libman, MD, PhD
    Recruiting
  • Vanderbilt University

    Nashville, Tennessee, United States

    Daniel Moore, MD
    Recruiting
  • University of Utah

    Salt Lake City, Utah, United States

    Zoe Raleigh, MD
    Recruiting
  • Benaroya Research Institute

    Seattle, Washington, United States

    Kurt Griffin, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 May 2026
Primary completion
25 May 2028
Completion
25 May 2028
Last update posted
18 Jun 2026
Registered enrollment
66
Registry id
NCT07142252
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.